Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve i. The unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech has informed BSE that its Board of Directors will meet on Thursday, 14th August 2025. The main agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26), along with the limited review report from the auditors. Any other business permitted by the Chair may also be taken up. The intimation has been filed under SEBI Listing Regulations, 2015. The letter is signed by Whole-time Director Swaminathan Govindarajan.
This is a routine procedural filing with no direct price impact. Investors should watch for the actual Q1 results on or after 14th August, as the numbers could drive short-term stock movement.